I am an associate attending medical physicist and the Chief Physicist at MSK Commack. I lead a group of excellent physicists and planners working closely with radiation oncologists and therapists to provide the safest and most effective clinical care. Our services include treatment planning, physics quality assurance, plan check, physics consultation, and implementing new advanced treatment techniques.
My research interests are in deformable image registration, four-dimensional optimization in radiotherapy, and developing new advanced techniques in image-guided radiation therapy and adaptive radiotherapy.
I received my PhD from the State University of New York at Stony Brook in 2003. I am a member of the American Association of Physicists in Medicine, and the American Society for Radiation Oncology. I was certified by the American Board of Radiology in 2008 with special expertise in therapeutic radiological physics and became a faculty member of MSK in 2016.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Tianfang Li discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures